Stockscreener 앱 받기
2.86
0.35%
0.010
시간 외 거래:
2.86
전일 마감가:
$2.85
열려 있는:
$2.82
하루 거래량:
307.11K
Relative Volume:
0.28
시가총액:
$265.11M
수익:
-
순이익/손실:
$-39.95M
주가수익비율:
-6.1519
EPS:
-0.4649
순현금흐름:
$-34.08M
1주 성능:
-4.35%
1개월 성능:
-9.21%
6개월 성능:
-42.80%
1년 성능:
-69.44%
1일 변동 폭
$2.81
$2.905
1주일 범위
$2.755
$2.9784
52주 변동 폭
$2.255
$10.40
Anavex Life Sciences Corp Stock (AVXL) Company Profile
명칭
Anavex Life Sciences Corp
전화
844-689-3939
주소
630 5TH AVENUE, NEW YORK
Compare AVXL vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
2.86 | 290.14M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | 개시 | Berenberg | Buy |
| 2021-09-23 | 개시 | BTIG Research | Buy |
| 2020-12-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-28 | 개시 | Ladenburg Thalmann | Buy |
| 2020-02-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-18 | 개시 | Janney | Buy |
| 2018-05-16 | 재개 | Maxim Group | Buy |
| 2018-03-08 | 개시 | ROTH Capital | Buy |
| 2018-02-13 | 재확인 | Maxim Group | Buy |
| 2017-09-29 | 재개 | Noble Financial | Buy |
| 2017-02-07 | 개시 | Noble Financial | Buy |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
모두보기
Anavex Life Sciences Corp 주식(AVXL)의 최신 뉴스
Anavex Life Sciences (AVXL) Board Shakeup Sparks Pre-Market Inte - GuruFocus
Anavex gains as PVG calls for board reshuffle (AVXL:NASDAQ) - Seeking Alpha
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 3, 2026) - Stock Titan
PVG Asset Management Pushes for Board Changes at Anavex Life Sci - GuruFocus
PVG Asset Management targets Anavex (NASDAQ: AVXL) board in 2026 vote push - Stock Titan
Anavex Life Sciences Regains Nasdaq Compliance After Filing Quarterly Reports - marketscreener.com
Anavex Life Sciences regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Anavex Life Sciences regains Nasdaq compliance after filing delayed 10-Qs - TradingView
Anavex Life Sciences regains Nasdaq compliance - Investing.com India
Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement - Anavex Life Sciences
Anavex will keep trading on Nasdaq after filing its outstanding reports - Stock Titan
AVXL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
New proxy contest hits Anavex (AVXL) as PVG presses its case for the 2026 shareholder vote - Stock Titan
PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting - The Manila Times
PVG Asset Management Corporation Files Definitive Proxy - GlobeNewswire
Anavex Life Sciences : Amendment to Annual Report (Form 10-K/A) - marketscreener.com
Anavex (AVXL) admits control weakness yet keeps Dec. 2025 numbers - Stock Titan
Anavex: After The EU Said No, The FDA Path Looks Long And Expensive - Seeking Alpha
Anavex Life Sciences Releases Q3 2026 Financial Results - AlphaStreet
Anavex Life Sciences reports Q3 FY2026 net income $7.8M, cash $118.3M - TradingView
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot - KING5.com
Anavex Life Sciences (AVXL) Sees Stock Surge Following Q3 Update and Regulatory Progress - GuruFocus
Anavex (AVXL) Momentum: Moves 7.67% Down to $3.13; Technical Setup: the $2.97 to $3.29 Range Remains in Focus on the DayRetail Volume - Vinanet
PVG mounts six-seat board challenge at Anavex (AVXL) - Stock Titan
Anavex Life Sciences Corp (AVXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anavex Life Sciences Releases Stockholder Letter and Press Release for 2026 Annual Meeting - Kalkine Media
Anavex Urges Shareholders to Back Six Director Nominees Ahead of 2026 Annual Meeting - Yahoo Finance
Form 8K Anavex Life Sciences Corp For: 17 August By Investing.com - Investing.com Canada
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees - The Manila Times
Six Anavex Director Nominees Face a Sept. 24 Vote—What Sets Them Apart? - Stock Titan
Promising Penny Stocks To Consider In August 2026 - Sahm
(AVXL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anavex Life Sciences Files Proxy, Urges Director Support - The Globe and Mail
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Anavex urges shareholders to back board slate amid proxy fight By Investing.com - Investing.com UK
Anavex Life Sciences files definitive proxy, urges vote for six director nominees ahead of Sept. 24 meeting - TradingView
Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances - Yahoo Finance
Anavex urges shareholders to back board slate amid proxy fight - Investing.com
Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders - The Manila Times
Anavex Life Sciences Files Definitive Proxy Statement and Urges Stockholders to Vote for All Six Director Nominees on WHITE Card - Quiver Quantitative
Anavex Life Sciences Corp Solicits Proxies from Shareholders - marketscreener.com
Anavex Life Sciences (NASDAQ:AVXL) Stock Crosses Above 50-Day Moving AverageWhat's Next? - MarketBeat
Anavex Life Sciences (NASDAQ: AVXL) delays two 2026 quarterly SEC reports - Stock Titan
AVXL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Anavex Life Sciences Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 509% Upside in Biotech - DirectorsTalk Interviews
Anavex Life Sciences Corp. Revenue Breakdown – NASDAQ:AVXL - TradingView
Anavex Life Sciences (NASDAQ:AVXL) Rallies Today on clinical-stage momentum - Kalkine Media
Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - anavex.com
Press Release: Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - moomoo.com
Weekly Recap: IND filing for blarcamesine and Q2 loss, cash runway - TradingView
Anavex Life Sciences Corp (AVXL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):